LIFECORE BIOMEDICAL, INC. Cost of Services (Deprecated 2018-01-31)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Cost of Services (Deprecated 2018-01-31) of $263.00 thousand for the 3-month period ending 2014-02-23, per its 10-Q filed 2014-03-28.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2014-03-28
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2014-02-23 was $263.00K, a 2.23% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2013-11-24 was $402.00K, a 17.62% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2013-08-25 was $517.00K, a 20.09% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2013-05-26 was $466.00K, a 28.09% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for fiscal 2013 was $1.87M, a 26.81% decline from fiscal 2012.
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for fiscal 2012 was $2.56M, a 10.88% decline from fiscal 2011.
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for fiscal 2011 was $2.87M, a 4.18% decline from fiscal 2010.
- LIFECORE BIOMEDICAL, INC. cost of services (deprecated 2018-01-31) for fiscal 2010 was $2.99M.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2014-02-23 | $263.00K 10-Q · filed 2014-03-28 | $665.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.18M 10-Q · filed 2014-03-28 | $1.65M derived: sum of 4 quarters · filed 2014-03-28 |
| 2013-11-24 | $402.00K 10-Q · filed 2014-01-03 | $919.00K 10-Q · filed 2014-01-03 | $1.39M derived: sum of 3 quarters · filed 2014-01-03 | $1.65M derived: sum of 4 quarters · filed 2014-03-28 |
| 2013-08-25 | $517.00K 10-Q · filed 2013-09-26 | $983.00K derived: sum of 2 quarters · filed 2013-09-26 | $1.25M derived: sum of 3 quarters · filed 2014-03-28 | $1.74M derived: sum of 4 quarters · filed 2014-03-28 |
| 2013-05-26 | $466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $735.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.22M derived: sum of 3 quarters · filed 2014-03-28 | $1.87M 10-K · filed 2013-08-07 |
| 2013-02-24 | $269.00K 10-Q · filed 2014-03-28 | $757.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.40M 10-Q · filed 2014-03-28 | $2.05M derived: sum of 4 quarters · filed 2014-03-28 |
| 2012-11-25 | $488.00K 10-Q · filed 2014-01-03 | $1.14M 10-Q · filed 2014-01-03 | $1.78M derived: sum of 3 quarters · filed 2014-01-03 | $2.24M derived: sum of 4 quarters · filed 2014-01-03 |
| 2012-08-26 | $647.00K 10-Q · filed 2013-09-26 | $1.29M derived: sum of 2 quarters · filed 2013-09-26 | $1.75M derived: sum of 3 quarters · filed 2013-09-26 | $2.42M derived: sum of 4 quarters · filed 2013-09-26 |
| 2012-05-27 | $648.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $1.11M derived: sum of 2 quarters · filed 2013-08-07 | $1.77M derived: sum of 3 quarters · filed 2013-08-07 | $2.56M 10-K · filed 2013-08-07 |
| 2012-02-26 | $460.00K 10-Q · filed 2013-04-04 | $1.13M derived: sum of 2 quarters · filed 2013-04-04 | $1.91M 10-Q · filed 2013-04-04 | $2.57M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-11-27 | $666.00K 10-Q · filed 2013-01-04 | $1.45M 10-Q · filed 2013-01-04 | $2.11M derived: sum of 3 quarters · filed 2013-08-07 | $2.59M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-08-28 | $782.00K 10-Q/A · filed 2013-01-02 | $1.44M derived: sum of 2 quarters · filed 2013-08-07 | $1.92M derived: sum of 3 quarters · filed 2013-08-07 | $2.80M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-05-29 | $659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $1.14M derived: sum of 2 quarters · filed 2013-08-07 | $2.02M derived: sum of 3 quarters · filed 2013-08-07 | $2.87M 10-K · filed 2013-08-07 |
| 2011-02-27 | $483.00K 10-Q · filed 2012-03-28 | $1.36M derived: sum of 2 quarters · filed 2012-03-28 | $2.21M 10-Q · filed 2012-03-28 | |
| 2010-11-28 | $875.00K 10-Q · filed 2012-01-05 | $1.73M 10-Q · filed 2012-01-05 | ||
| 2010-08-29 | $850.00K 10-Q · filed 2011-10-05 | |||
| 2010-05-30 | $2.99M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |